Profile | GDS2987 / GI_21361432-S |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | 283.9 | 86 |
GSM215244 | HMVEC_vehicle_rep2 | 364.3 | 88 |
GSM215253 | HMVEC_vehicle_rep3 | 336.3 | 88 |
GSM215254 | HMVEC_atorvastatin_rep1 | 73.2 | 73 |
GSM215282 | HMVEC_atorvastatin_rep3 | 78.2 | 73 |
GSM215344 | HMVEC_atorvastatin_rep2 | 89 | 74 |
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | 318.1 | 86 |
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | 359.8 | 87 |
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | 307.7 | 86 |
GSM215294 | HMVEC_SLx2119_rep1 | 124.5 | 79 |
GSM215295 | HMVEC_SLx2119_rep2 | 91.4 | 74 |
GSM215296 | HMVEC_SLx2119_rep3 | 125.9 | 77 |
GSM215297 | PASMC_vehicle_rep1 | ||
GSM215298 | PASMC_vehicle_rep2 | ||
GSM215310 | PASMC_vehicle_rep3 | 37 | 51 |
GSM215311 | PASMC_atorvastatin_rep1 | ||
GSM215312 | PASMC_atorvastatin_rep2 | ||
GSM215313 | PASMC_atorvastatin_rep3 | 5.2 | 8 |
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | ||
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | ||
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | ||
GSM215327 | PASMC_SLx2119_rep1 | 60.1 | 67 |
GSM215328 | PASMC_SLx2119_rep2 | 72.9 | 71 |
GSM215329 | PASMC_SLx2119_rep3 | 83.9 | 73 |
GSM215330 | Fibroblasts_vehicle_rep1 | 691.6 | 92 |
GSM215331 | Fibroblasts_vehicle_rep2 | 782.9 | 93 |
GSM215332 | Fibroblasts_vehicle_rep3 | 735.7 | 93 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | 710.7 | 92 |
GSM215334 | Fibroblasts_atorvastatin_rep2 | 824.9 | 93 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | 844.3 | 93 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 853.1 | 93 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 746 | 93 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 862.1 | 93 |
GSM215339 | Fibroblasts_SLx2119_rep1 | 791.1 | 93 |
GSM215340 | Fibroblasts_SLx2119_rep2 | 806.9 | 93 |
GSM215341 | Fibroblasts_SLx2119_rep3 | 804 | 93 |